Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 82% ± 11% | |
lung | 19 studies | 71% ± 17% | |
brain | 16 studies | 39% ± 18% | |
intestine | 13 studies | 63% ± 24% | |
eye | 11 studies | 43% ± 21% | |
kidney | 9 studies | 75% ± 18% | |
liver | 8 studies | 59% ± 24% | |
lymph node | 7 studies | 80% ± 14% | |
bone marrow | 6 studies | 66% ± 23% | |
uterus | 6 studies | 72% ± 26% | |
pancreas | 5 studies | 77% ± 18% | |
prostate | 5 studies | 61% ± 26% | |
placenta | 4 studies | 81% ± 18% | |
breast | 4 studies | 85% ± 5% | |
ovary | 3 studies | 50% ± 21% | |
heart | 3 studies | 43% ± 16% | |
adipose | 3 studies | 50% ± 27% | |
adrenal gland | 3 studies | 73% ± 13% | |
esophagus | 3 studies | 78% ± 18% | |
skin | 3 studies | 66% ± 16% | |
thymus | 3 studies | 83% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 22918.75 | 1445 / 1445 | 100% | 327.16 | 183 / 183 |
intestine | 100% | 18211.28 | 966 / 966 | 100% | 252.39 | 527 / 527 |
ovary | 100% | 13867.61 | 180 / 180 | 100% | 326.74 | 430 / 430 |
prostate | 100% | 14575.97 | 245 / 245 | 100% | 144.77 | 502 / 502 |
skin | 100% | 30601.10 | 1809 / 1809 | 100% | 218.70 | 472 / 472 |
stomach | 100% | 12983.26 | 359 / 359 | 100% | 257.77 | 286 / 286 |
uterus | 100% | 14882.21 | 170 / 170 | 100% | 225.17 | 459 / 459 |
kidney | 100% | 21437.62 | 89 / 89 | 100% | 151.95 | 900 / 901 |
brain | 100% | 21369.68 | 2639 / 2642 | 100% | 207.73 | 705 / 705 |
thymus | 100% | 17046.12 | 653 / 653 | 100% | 150.59 | 604 / 605 |
lung | 100% | 20689.94 | 577 / 578 | 100% | 202.34 | 1155 / 1155 |
breast | 100% | 18584.30 | 459 / 459 | 100% | 204.35 | 1116 / 1118 |
bladder | 100% | 18259.81 | 21 / 21 | 100% | 228.72 | 503 / 504 |
liver | 100% | 12919.29 | 225 / 226 | 100% | 134.24 | 406 / 406 |
adrenal gland | 100% | 19062.95 | 258 / 258 | 99% | 134.02 | 228 / 230 |
pancreas | 99% | 10276.39 | 325 / 328 | 99% | 150.06 | 177 / 178 |
adipose | 100% | 19394.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 185.81 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 300.24 | 29 / 29 |
spleen | 100% | 20684.89 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 212.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 99.73 | 1 / 1 |
blood vessel | 100% | 19068.15 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 8901.16 | 827 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 18011.54 | 855 / 929 | 0% | 0 | 0 / 0 |
muscle | 77% | 6010.06 | 622 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060352 | Biological process | cell adhesion molecule production |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0032148 | Biological process | activation of protein kinase B activity |
GO_0035307 | Biological process | positive regulation of protein dephosphorylation |
GO_0070527 | Biological process | platelet aggregation |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_1902176 | Biological process | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0030595 | Biological process | leukocyte chemotaxis |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0042118 | Biological process | endothelial cell activation |
GO_0045069 | Biological process | regulation of viral genome replication |
GO_0045070 | Biological process | positive regulation of viral genome replication |
GO_0030168 | Biological process | platelet activation |
GO_0032873 | Biological process | negative regulation of stress-activated MAPK cascade |
GO_0050714 | Biological process | positive regulation of protein secretion |
GO_0006457 | Biological process | protein folding |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0030182 | Biological process | neuron differentiation |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0034389 | Biological process | lipid droplet organization |
GO_0019076 | Biological process | viral release from host cell |
GO_0006915 | Biological process | apoptotic process |
GO_1903901 | Biological process | negative regulation of viral life cycle |
GO_2001233 | Biological process | regulation of apoptotic signaling pathway |
GO_0061944 | Biological process | negative regulation of protein K48-linked ubiquitination |
GO_0000413 | Biological process | protein peptidyl-prolyl isomerization |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005925 | Cellular component | focal adhesion |
GO_0034774 | Cellular component | secretory granule lumen |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0031982 | Cellular component | vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
GO_1904399 | Molecular function | heparan sulfate binding |
GO_0005178 | Molecular function | integrin binding |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0046790 | Molecular function | virion binding |
GO_0016018 | Molecular function | cyclosporin A binding |
Gene name | PPIA |
Protein name | Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed] Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) Peptidylprolyl isomerase A |
Synonyms | CYPA |
Description | FUNCTION: Catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides . Exerts a strong chemotactic effect on leukocytes partly through activation of one of its membrane receptors BSG/CD147, initiating a signaling cascade that culminates in MAPK/ERK activation . Activates endothelial cells (ECs) in a pro-inflammatory manner by stimulating activation of NF-kappa-B and ERK, JNK and p38 MAP-kinases and by inducing expression of adhesion molecules including SELE and VCAM1 . Induces apoptosis in ECs by promoting the FOXO1-dependent expression of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis . In response to oxidative stress, initiates proapoptotic and antiapoptotic signaling in ECs via activation of NF-kappa-B and AKT1 and up-regulation of antiapoptotic protein BCL2 . Negatively regulates MAP3K5/ASK1 kinase activity, autophosphorylation and oxidative stress-induced apoptosis mediated by MAP3K5/ASK1 . Necessary for the assembly of TARDBP in heterogeneous nuclear ribonucleoprotein (hnRNP) complexes and regulates TARDBP binding to RNA UG repeats and TARDBP-dependent expression of HDAC6, ATG7 and VCP which are involved in clearance of protein aggregates . Plays an important role in platelet activation and aggregation (By similarity). Regulates calcium mobilization and integrin ITGA2B:ITGB3 bidirectional signaling via increased ROS production as well as by facilitating the interaction between integrin and the cell cytoskeleton (By similarity). Binds heparan sulfate glycosaminoglycans . Inhibits replication of influenza A virus (IAV) . Inhibits ITCH/AIP4-mediated ubiquitination of matrix protein 1 (M1) of IAV by impairing the interaction of ITCH/AIP4 with M1, followed by the suppression of the nuclear export of M1, and finally reduction of the replication of IAV . .; FUNCTION: (Microbial infection) May act as a mediator between human SARS coronavirus nucleoprotein and BSG/CD147 in the process of invasion of host cells by the virus . .; FUNCTION: (Microbial infection) Stimulates RNA-binding ability of HCV NS5A in a peptidyl-prolyl cis-trans isomerase activity-dependent manner. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . FUNCTION: PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . |
Accessions | ENST00000677107.1 [P62937-2] ENST00000678789.1 [P62937-2] ENST00000415933.5 ENST00000676977.1 C9J5S7 A0A7P0S768 E5RIZ5 A0A7I2V5J5 ENST00000620047.5 ENST00000480603.1 ENST00000355968.10 [P62937-2] ENST00000678805.1 [P62937-2] ENST00000451562.5 P62937 ENST00000479021.1 ENST00000468812.6 [P62937-1] ENST00000677022.1 [P62937-2] A0A7I2V4V1 F8WE65 ENST00000489459.5 [P62937-2] |